MONTEFIORE MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $69.4M
- Transactions
- 5,526
- Companies
- 40
- Average per transaction
- $12,558
Who reported the payments
| AbbVie | $17,558,290 |
| Novartis | $5,767,237 |
| Merck | $4,502,750 |
| Janssen Research & Development, LLC | $3,957,835 |
| Pfizer | $2,231,349 |
| Genentech, Inc. | $2,002,817 |
| Amgen | $1,741,861 |
| Johnson & Johnson | $1,673,000 |
| Gilead | $1,668,692 |
| Bayer | $1,629,082 |
| Janssen Scientific Affairs, LLC | $1,388,261 |
| Regeneron | $1,270,114 |
| Biosense Webster, Inc. | $1,132,944 |
| Abbott | $1,048,956 |
| AstraZeneca | $971,848 |
| Jazz Pharmaceuticals Inc. | $971,370 |
| United Therapeutics Corporation | $900,725 |
| Pacira Pharmaceuticals Incorporated | $878,574 |
| E.r. Squibb & Sons, L.L.C. | $845,508 |
| Sanofi | $789,050 |
| Radiometer America, Inc | $782,413 |
| 3M Company | $743,820 |
| Global Blood Therapeutics, Inc. | $646,941 |
| Takeda Pharmaceuticals U.S.A., Inc. | $539,260 |
| Edwards Lifesciences | $495,929 |
| Lilly USA, LLC | $464,300 |
| Pharmacyclics LLC, An Abbvie Company | $455,000 |
| Portola Pharmaceuticals, LLC | $452,930 |
| Coloplast | $400,000 |
| Solventum Corporation | $397,380 |
| Lundbeck LLC | $379,900 |
| LEO Pharma Inc. | $377,075 |
| Philips North America LLC | $336,073 |
| Deciphera Pharmaceuticals Inc. | $332,824 |
| Medtronic | $332,577 |
| Novo Nordisk | $326,875 |
| Seagen Inc. | $322,030 |
| Biotronik Inc. | $316,519 |
| GSK | $315,485 |
| Incyte Corporation | $309,652 |